Loading...
XJPX
2784
Market cap2.71bUSD
Dec 05, Last price  
2,320.00JPY
1D
-1.94%
1Q
1.82%
Jan 2017
19.96%
IPO
78.46%
Name

Alfresa Holdings Corp

Chart & Performance

D1W1MN
XJPX:2784 chart
P/E
15.39
P/S
0.14
EPS
150.73
Div Yield, %
1.55%
Shrs. gr., 5y
-2.59%
Rev. gr., 5y
1.87%
Revenues
2.96t
+3.59%
1,411,691,000,0001,589,881,000,0001,769,384,000,0001,934,893,000,0002,059,328,000,0002,183,356,000,0002,333,465,000,0002,387,435,000,0002,504,574,000,0002,421,105,000,0002,576,360,000,0002,551,919,000,0002,602,925,000,0002,640,529,000,0002,698,555,000,0002,603,263,000,0002,585,643,000,0002,696,069,000,0002,858,500,000,0002,961,051,000,000
Net income
27.39b
-7.33%
7,073,000,00011,941,000,00016,177,000,0005,565,000,00010,497,000,0006,587,000,0006,604,000,00020,771,000,00025,566,000,00022,922,000,00034,975,000,00030,893,000,00035,589,000,00041,699,000,00040,273,000,00024,501,000,00032,182,000,00025,786,000,00029,558,000,00027,390,000,000
CFO
5.64b
-93.47%
24,665,000,00039,993,000,000-8,246,000,00032,963,000,0006,898,000,00052,233,000,00014,620,000,00082,339,000,000-27,507,000,00035,813,000,00037,836,000,00034,342,000,00047,575,000,00046,880,000,00033,828,000,000-21,191,000,00036,546,000,00013,086,000,00086,379,000,0005,639,000,000
Dividend
Mar 30, 202634 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
IPO date
Sep 29, 2003
Employees
11,772
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT